Exagen (XGN) Return on Sales (2018 - 2026)

Exagen (XGN) has reported Return on Sales for 9 consecutive years, with 0.0% the latest figure, recorded in Q1 2026.

• Return on Sales for Q1 2026 came in at 0.0%, changed 0.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY), and the FY2025 annual result was 0.0%, changed 0.0% from the prior year.
• Return on Sales was 0.0% for Q1 2026 at Exagen, up from 0.0% in the prior quarter.
• Over five years, Return on Sales peaked at 0.0% in Q2 2024 and troughed at 0.02% in Q2 2022.
• Average Return on Sales over 5 years is 0.01%, with a median of 0.0% recorded in 2024.
• Year-over-year, Return on Sales declined 1 bps in 2022 and climbed 2 bps in 2023.
• Over 5 years, Return on Sales stood at 0.01% in 2022, then soared by 66 bps to 0.0% in 2023, then jumped by 32 bps to 0.0% in 2024, then retreated by 2 bps to 0.0% in 2025, then rose by 18 bps to 0.0% in 2026.
• Per Business Quant data, the three most recent Return on Sales figures were 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.